CareTrust REIT, Inc. (CTRE) — closed signal from March 13, 2026
Partial Published before the outcome was known, scored automatically when the window closed on June 11, 2026.
Predicted vs. what happened
What happened
Reached 47% of the predicted growth at its peak, without hitting the target.
The thesis — published March 13, 2026
CareTrust is a steady healthcare real estate company showing improving results and reasonable valuation. A clear event - joining a mid-cap index - could bring automatic buying from investment funds and more attention. The stock is sensitive to interest rates and trades lightly, so this is better for patient buyers who add gradually rather than chase quick gains.
Primary drivers
- Index inclusion could bring automatic buying from funds
- Properties generate predictable rent and cash flow
- Recent valuation work suggests room for price improvement
- Earnings trends support a gradual upward re-rating
How it played out
CTRE: the target was not reached
Lyra published CTRE at 40.94 on 2026-03-13 with an expected gain of 11%. The thesis pointed to mid-cap index inclusion as a possible source of automatic fund buying, predictable rent and cash flow from the property base, valuation work that suggested room for price improvement, and earnings trends that supported a gradual upward re-rating.
Inside the window, CTRE rose to a peak of 43.08 on 2026-05-14, a gain of 5.2%. It stayed below the 45.44 target. The stock ended the window at 36.75 on 2026-06-11. The thesis partially played out, but the target was missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.